Rebaudioside affords hepatoprotection ameliorating sugar sweetened beverage- induced nonalcoholic steatohepatitis

Scientific Reports

Volumn 10, Issue 1, 2020, Pages

  Xi, Dong ^a   Bhattacharjee, Jashdeep ^a   Salazar Gonzalez, Rosa Maria ^a   Park, Soyoung ^b   Jang, Alice ^b   Warren, Mikako ^c   Merritt, Russell ^a   Michail, Sonia ^a   Bouret, Sebastien ^b   Kohli, Rohit ^a  

^a Hepatology and Nutrition   (United States)

^b Div of Endocrinology and Metabolism   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSE; GLUCOSE; KAURANE DERIVATIVE; PROTECTIVE AGENT; REBAUDIOSIDE A;

ADVERSE EVENT; ANIMAL; BODY WEIGHT GAIN; DRUG EFFECT; ENDOPLASMIC RETICULUM STRESS; ENERGY METABOLISM; HOMEOSTASIS; INSULIN RESISTANCE; LIPID DIET; LIVER; METABOLISM; MICROFLORA; MOUSE; NONALCOHOLIC FATTY LIVER; OBESITY; PANCREAS ISLET BETA CELL; PATHOLOGY; PATHOPHYSIOLOGY;

ADIPOSITY; ANIMALS; DIET, HIGH-FAT; DITERPENES, KAURANE; ENDOPLASMIC RETICULUM STRESS; ENERGY METABOLISM; FRUCTOSE; GLUCOSE; HOMEOSTASIS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LIVER; MICE; MICROBIOTA; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PROTECTIVE AGENTS; SUGAR-SWEETENED BEVERAGES; WEIGHT GAIN;

EID: 85083785235     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-020-63688-z     Document Type: Article

References (54)

1. Markova, M. et al. Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes. Gastroenterology, 10.1053/j.gastro.2016.10.007 (2017).
2. Della Corte, C. et al. Good adherence to the Mediterranean diet reduces the risk for NASH and diabetes in pediatric patients with obesity: The results of an Italian Study. Nutrition, 10.1016/j.nut.2017.02.008 (2017).
3. Promrat, K. et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 51, 121–129 (2010).
4. Li, Z. Z., Berk, M., McIntyre, T. M. & Feldstein, A. E. Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: Role of stearoyl-Coa desaturase. J. Biol. Chem. 284, 5637–5644 (2009).
5. Yamaguchi, K. et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology 45, 1366–1374 (2007).
6. Sanyal, A. et al. BMS-986036 (pegylated FGF21) in patients with non-alcoholic steatohepatitis: a phase 2 study. J. Hepatol. 66, S89–S90 (2017).
7. Harrison, S. A. et al. NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet 391, 1174–1185 (2018).
8. Armstrong, M. J. et al. Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): A multicentre, double-blind, randomised, placebo-controlled phase 2 study. Lancet 387, 679–690 (2016).
9. Mikolasevic, I. et al. Nonalcoholic fatty liver disease and liver transplantation - Where do we stand? World Journal of Gastroenterology 24, 1491–1506 (2018).
10. Prakash, I., Chaturvedula, V. S. P. & Markosyan, A. Isolation, characterization and sensory evaluation of a hexa??-d-glucopyranosyl diterpene from stevia rebaudiana. Nat. Prod. Commun., 10.1177/1934578x1300801106 (2013).
11. Anton, S. D. et al. Effects of stevia, aspartame, and sucrose on food intake, satiety, and postprandial glucose and insulin levels. Appetite 55, 37–43 (2010).
12. Park, J. E. & Cha, Y. S. Stevia rebaudiana Bertoni extract supplementation improves lipid and carnitine profiles in C57BL/6J mice fed a high-fat diet. J. Sci. Food Agric 90, 1099–1105 (2010).
13. Turnbaugh, P. J. et al. The effect of diet on the human gut microbiome: A metagenomic analysis in humanized gnotobiotic mice. Sci. Transl. Med. 1 (2009).
14. Henao-Mejia, J. et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482, 179–185 (2012).
15. Alkhouri, N. & Feldstein, A. E. The TONIC trial: A step forward in treating pediatric nonalcoholic fatty liver disease. Hepatology 55, 1292–1295 (2012).
16. Holscher, H. D. Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut. Microbes 8, 172–184 (2017).
17. Everard, A. et al. Intestinal epithelial N-acylphosphatidylethanolamine phospholipase D links dietary fat to metabolic adaptations in obesity and steatosis. Nat. Commun. 10 (2019).
18. Suez, J. et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 514, 181–186 (2014).
19. Geuns, J. M. C., Augustijns, P., Mols, R., Buyse, J. G. & Driessen, B. Metabolism of stevioside in pigs and intestinal absorption characteristics of stevioside, rebaudioside A and steviol. Food Chem. Toxicol., 10.1016/S0278-6915(03)00191-1 (2003).
20. Giacaman, R. A., Campos, P., Muñoz-Sandoval, C. & Castro, R. J. Cariogenic potential of commercial sweeteners in an experimental biofilm caries model on enamel. Arch. Oral. Biol., 10.1016/j.archoralbio.2013.03.005 (2013).
21. Gregersen, S., Jeppesen, P. B., Holst, J. J. & Hermansen, K. Antihyperglycemic effects of stevioside in type 2 diabetic subjects. Metabolism., 10.1016/j.metabol.2003.07.013 (2004).
22. Bloom, S. R. & Edwards, A. V. The release of pancreatic glucagon and inhibition of insulin in response to stimulation of the sympathetic innervation. J. Physiol 253, 157–173 (1975).
23. Marliss, E. B. et al. Glucagon release induced by pancreatic nerve stimulation in the dog. J. Clin. Invest. 52, 1246–1259 (1973).
24. Crichton, G., Alkerwi, A. & Elias, M. Diet Soft Drink Consumption is Associated with the Metabolic Syndrome: A Two Sample Comparison. Nutrients 7, 3569–3586 (2015).
25. Duffey, K. J., Steffen, L. M., Van Horn, L., Jacobs, D. R. & Popkin, B. M. Dietary patterns matter: diet beverages and cardiometabolic risks in the longitudinal Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am. J. Clin. Nutr. 95, 909–915 (2012).
26. Gregersen, S., Jeppesen, P. B., Holst, J. J. & Hermansen, K. Antihyperglycemic effects of stevioside in type 2 diabetic subjects. Metabolism. 53, 73–76 (2004).
27. Hsieh, M. H. et al. Efficacy and Tolerability of Oral Stevioside in Patients with Mild Essential Hypertension: A Two-Year, Randomized, Placebo-Controlled Study. Clin. Ther. 25, 2797–2808 (2003).
28. Nettleton, J. A. et al. Diet Soda Intake and Risk of Incident Metabolic Syndrome and Type 2 Diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 32, 688–694 (2009).
29. Sharma, N., Mogra, R. & Upadhyay, B. Effect of stevia extract intervention on lipid profile. Stud. Ethno-Medicine 3, 137–140 (2009).
30. Zhu, Y. et al. Maternal consumption of artificially sweetened beverages during pregnancy, and offspring growth through 7 years of age: A prospective cohort study. Int. J. Epidemiol 46, 1499–1508 (2017).
31. Azad, M. B. et al. Association between artificially sweetened beverage consumption during pregnancy and infant body mass index. JAMA Pediatr 170, 662–670 (2016).
32. Ramos-Tovar, E. et al. Stevia prevents acute and chronic liver injury induced by carbon tetrachloride by blocking oxidative stress through Nrf2 upregulation. Oxid. Med. Cell. Longev. 2018 (2018).
33. Koyama, E. et al. In vitro metabolism of the glycosidic sweeteners, stevia mixture and enzymatically modified stevia in human intestinal microflora. Food Chem. Toxicol. 41, 359–74 (2003).
34. Gardana, C., Simonetti, P., Canzi, E., Zanchi, R. & Pietta, P. Metabolism of Stevioside and Rebaudioside A from Stevia rebaudiana Extracts by Human Microflora. J. Agric. Food Chem. 51, 6618–6622 (2003).
35. Wang, Y. et al. New application of the commercial sweetener rebaudioside a as a hepatoprotective candidate: Induction of the Nrf2 signaling pathway. Eur. J. Pharmacol. 822, 128–137 (2018).
36. Hinz, B., Dugina, V., Ballestrem, C., Wehrle-Haller, B. & Chaponnier, C. Alpha-smooth muscle actin is crucial for focal adhesion maturation in myofibroblasts. Mol. Biol. Cell 14, 2508–19 (2003).
37. Li, M. et al. ATF6 as a Transcription Activator of the Endoplasmic Reticulum Stress Element: Thapsigargin Stress-Induced Changes and Synergistic Interactions with NF-Y and YY1. Mol. Cell. Biol. 20, 5096–5106 (2000).
38. Wang, P., Li, J., Tao, J. & Sha, B. The luminal domain of the ER stress sensor protein PERK binds misfolded proteins and thereby triggers PERK oligomerization. J. Biol. Chem. 293, 4110–4121 (2018).
39. Li, H., Korennykh, A. V., Behrman, S. L. & Walter, P. Mammalian endoplasmic reticulum stress sensor IRE1 signals by dynamic clustering. Proc. Natl. Acad. Sci. USA. 107, 16113–16118 (2010).
40. Heindryckx, F. et al. Endoplasmic reticulum stress enhances fibrosis through IRE1α-mediated degradation of miR-150 and XBP-1 splicing. EMBO Mol. Med. 8, 729–744 (2016).
41. Bian, X. et al. Saccharin induced liver inflammation in mice by altering the gut microbiota and its metabolic functions. Food Chem. Toxicol. 107, 530–539 (2017).
42. Bian, X. et al. Gut microbiome response to sucralose and its potential role in inducing liver inflammation in mice. Front. Physiol. 8 (2017).
43. Naim, M., Sandovsky, V., Zechman, J. M., Brand, J. G. & Kare, M. R. Effects of Sodium Saccharin on the Activity of Trypsin, Chymotrypsin, and Amylase and upon Bacteria in Small Intestinal Contents of Rats. Proc. Soc. Exp. Biol. Med. 178, 392–401 (1985).
44. Palmnäs, M. S. A. et al. Low-dose aspartame consumption differentially affects gut microbiota-host metabolic interactions in the diet-induced obese rat. Plos One 9 (2014).
45. Frankenfeld, C. L., Sikaroodi, M., Lamb, E., Shoemaker, S. & Gillevet, P. M. High-intensity sweetener consumption and gut microbiome content and predicted gene function in a cross-sectional study of adults in the United States. Ann. Epidemiol. 25, 736–742.e4 (2015).
46. Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027–1031 (2006).
47. Santacruz, A. et al. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br. J. Nutr. 104, 83–92 (2010).
48. Payahoo, L. et al. Investigation the effect of oleoylethanolamide supplementation on the abundance of Akkermansia muciniphila bacterium and the dietary intakes in people with obesity: A randomized clinical trial. Appetite 141 (2019).
49. Sheng, L. et al. Obesity treatment by epigallocatechin-3-gallate–regulated bile acid signaling and its enriched Akkermansia muciniphila. FASEB J. 32, 6371–6384 (2018).
50. Syafruddin, S. E. et al. A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in renal carcinoma. Nat. Commun. 10, 1–13 (2019).
51. Bouret, S. G., Draper, S. J. & Simerly, R. B. Trophic Action of Leptin on Hypothalamic Neurons That Regulate Feeding. Science (80-.) 304, 108–110 (2004).
52. Bochukova, E. G. et al. A Transcriptomic Signature of the Hypothalamic Response to Fasting and BDNF Deficiency in Prader-Willi Syndrome. Cell Rep 22, 3401–3408 (2018).
53. Walters, W. et al. Improved Bacterial 16S rRNA Gene (V4 and V4-5) and Fungal Internal Transcribed Spacer Marker Gene Primers for Microbial Community Surveys. mSystems 1(1), pii: e00009-15 (2015).
54. Caporaso, J. G. et al. Moving pictures of the human microbiome. Genome Biol. 12 (2011).